New Hampshire SB455 mandates Medicaid coverage for GLP-1 medication for qualifying patients.
New Hampshire SB455 amends the state Medicaid plan to include coverage for GLP-1 medication. This coverage applies if a licensed healthcare provider determines the medication is medically necessary and the patient meets specific criteria: a BMI of 30 or higher, or a BMI of 27 or higher with weight-related comorbidities such as Type 2 diabetes, hypertension, dyslipidemia, obstructive sleep apnea, cardiovascular disease, prediabetes, or metabolic dysfunction associated steatotic liver disease.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.